Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
WuXi ATU Opens New Manufacturing Facility to Further Enhance Its CTDMO Services for Global Customers 2021-10-18 11:05
CellOrigin secured a new round of investment for developing its globally proprietary iPSC-CAR-Macrophage technology platform 2021-10-15 20:50
GV20 Oncotherapy Completes Series B Financing to Advance Pipeline into the Clinic and Expand Immuno-Oncology Drug Discovery Platform 2021-10-14 23:55
BioAgilytix Closes Acquisition of Australia-based 360biolabs® 2021-10-14 19:00
I-Mab Advances Late-stage Development of Its Differentiated CD38 Antibody Felzartamab (TJ202) in China 2021-10-13 20:00
AUM Biosciences announces closing of USD $27Million in a "Series A" Round of funding to advance its clinical stage pipeline of precision and targeted cancer therapies 2021-10-13 02:30
NeoPlex (TM) HPV29 Detection, a new molecular detection kit from Genematrix, acquires European CE-IVD certification 2021-10-12 16:00
ProfoundBio Announces Presentation on Novel, Proprietary Linker-Drug Technology to Enable Antibody-Drug Conjugates (ADCs) with an Expanded Therapeutic Window at the AACR-NCI-EORTC International Conference 2021-10-08 11:39
Amplo Biotechnology Closes Series Seed Financing to Advance Gene Therapies for The Treatment of Neuromuscular Junction Disorders 2021-10-06 23:30
I-Mab Announces Upcoming Participation at October Conferences 2021-10-01 20:00
Binhai sets ambitious biomedical goals with support of key companies 2021-10-01 01:08
Penn mRNA Biology Pioneer Drew Weissman Joins RVAC's Science Advisory Board 2021-10-01 00:50
I-Mab Reports Multiple Positive Clinical Updates of Differentiated CD47 Antibody Lemzoparlimab 2021-09-30 20:00
GenFleet and Innovent Starts First-in-human Phase I/II Trial of KRAS G12C Inhibitor 2021-09-30 08:05
Neurophth Announces the Completion of GMP Manufacturing Facility for Gene Therapy Products According to International Standards 2021-09-27 23:00
Harbour BioMed Announces Dosing of First Patient of Batoclimab Phase III Trial in Patients with Generalized Myasthenia Gravis 2021-09-27 21:03
Senhwa Announces Acceptance of Early Positive COVID-19 Phase II Study Abstract for Presentation at the ISIRV-WHO Conference 2021-09-27 19:20
Transcenta Received IND Clearance from NMPA of its Anti-sclerostin Monoclonal Antibody TST002 2021-09-27 08:30
GenScript ProBio and AskGene Enter into a Non-exclusive License of A sdAb Targeting Immune Checkpoint Target 2021-09-26 22:28
Boan Biotech to Present the Pre-clinical Data of Its Proprietary CD3+ T-cell Engager Platform and CEA/CD3 Bispecific Antibody at World Bispecific Summit 2021-09-26 10:12
1 98 99 100 101 102 222